Norbert Müller

Active 1959–2024

Also published as
Norbert MÜller
140
Papers
19,980
Citations
86
h-index
130
i10-index

Citations

Citations per year for Norbert Müller1959: 2 citations1960: 1 citations1961: 2 citations1963: 1 citations1964: 1 citations1965: 2 citations1967: 4 citations1968: 2 citations1974: 1 citations1975: 1 citations1977: 2 citations1979: 5 citations1980: 2 citations1981: 1 citations1982: 6 citations1983: 3 citations1984: 1 citations1986: 2 citations1987: 1 citations1989: 9 citations1990: 2 citations1991: 10 citations1992: 8 citations1993: 10 citations1994: 5 citations1995: 17 citations1996: 19 citations1997: 12 citations1998: 22 citations1999: 38 citations2000: 70 citations2001: 60 citations2002: 61 citations2003: 55 citations2004: 54 citations2005: 67 citations2006: 74 citations2007: 106 citations2008: 102 citations2009: 150 citations2010: 158 citations2011: 169 citations2012: 227 citations2013: 220 citations2014: 201 citations2015: 182 citations2016: 153 citations2017: 167 citations2018: 122 citations2019: 451 citations2020: 480 citations2021: 509 citations2022: 417 citations2023: 272 citations2024: 434 citations2025: 190 citations2026: 5 citations1962: no citations, so this year is not shown1966: no citations, so this year is not shown1969–1973: no citations, so these years are not shown1976: no citations, so this year is not shown1978: no citations, so this year is not shown1985: no citations, so this year is not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,297 citing papers, 19.3% of this breakdownGermany: 521 citing papers, 7.8% of this breakdownChina: 486 citing papers, 7.3% of this breakdownUnited Kingdom: 449 citing papers, 6.7% of this breakdownItaly: 333 citing papers, 5% of this breakdownCanada: 281 citing papers, 4.2% of this breakdownAustralia: 255 citing papers, 3.8% of this breakdownSpain: 210 citing papers, 3.1% of this breakdownFrance: 190 citing papers, 2.8% of this breakdownSwitzerland: 187 citing papers, 2.8% of this breakdownNetherlands: 184 citing papers, 2.7% of this breakdownBrazil: 161 citing papers, 2.4% of this breakdown
0%19.3%Other 32.1%

Fields

  • Neuroscience41.7%
  • Medicine22.9%
  • Biochemistry, Genetics and Molecular Biology11.2%
  • Immunology and Microbiology7.6%
  • Psychology4.9%
  • Physics and Astronomy2.9%
  • Other8.8%

Topics

  • Tryptophan and brain disorders14.9%
  • Stress Responses and Cortisol7.7%
  • Neuroinflammation and Neurodegeneration Mechanisms4.1%
  • Schizophrenia research and treatment3.2%
  • Parasitic Infections and Diagnostics2.1%
  • Bipolar Disorder and Treatment1.9%
  • Other66.1%

Coauthors

All papers

Open in search
  1. Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations

    Authors: - Schizophrenia Bulletin 2018 cited by 642

  2. Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium

    Authors: , , , , , , , , , - Frontiers in Psychiatry 2019 cited by 230

  3. The role of inflammation in schizophrenia

    Authors: , , , - Frontiers in Neuroscience 2015 cited by 461

  4. Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders

    Authors: , , , , , , - Frontiers in Immunology 2021 cited by 95

  5. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

    Authors: , - Molecular Psychiatry 2007 cited by 670

  6. Depression and suicidality: A link to premature T helper cell aging and increased Th17 cells

    Authors: , , , , , , , , - Brain Behavior and Immunity 2020 cited by 110

  7. Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression

    Authors: , , , , , , , , , , , , , , , , , , , , , - Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021 cited by 94

  8. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

    Authors: , , , , , , , , , , , , - Molecular Psychiatry 2006 cited by 795

  9. The Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Psychiatric Disorders

    Authors: - Frontiers in Pharmacology 2019 cited by 168

  10. Laboratory Diagnosis of Echinococcus spp. in Human Patients and Infected Animals

    Authors: , , , - Advances in Parasitology/Advances in parasitology 2017 cited by 189

  11. Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in Schizophrenia

    Authors: , , , , , , , , , - American Journal of Psychiatry 2002 cited by 389

  12. Comparative Study on the Antioxidant and Biological Activities of Carvacrol, Thymol, and Eugenol Derivatives

    Authors: , , , , , , , , , , - Journal of Agricultural and Food Chemistry 2008 cited by 307

  13. The Role of Immune System in Schizophrenia

    Authors: , - Current Immunology Reviews 2010 cited by 295

  14. Immunology of Major Depression

    Authors: - NeuroImmunoModulation 2014 cited by 173

  15. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment

    Authors: , , , , , , , - Journal of Affective Disorders 2011 cited by 126

  16. COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders

    Authors: - Frontiers in Psychiatry 2019 cited by 112

  17. Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression

    Authors: , , , , , , , , , , , - Translational Psychiatry 2020 cited by 60

  18. Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study

    Authors: , , , , , , , , , , , , - European Archives of Psychiatry and Clinical Neuroscience 2015 cited by 79

  19. Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pieter J. Hoekstra, Chaim Huyser, Marcos Madruga‐Garrido, A Marotta, Davide Martino, Pablo Mir, Ástrid Morer, Norbert Müller, Kirsten Müller‐Vahl, Alexander Münchau, Péter Nagy, Valeria Neri, Thaïra J. C. Openneer, Alessandra Pellico, Kerstin Jessica Plessen, Cesare Porcelli, Renata Rizzo, Veit Roessner, Daphna Ruhrman, Jaana Schnell, Paola Rosaria Silvestri, Liselotte Skov, Tamar Steinberg, Friederike Tagwerker Gloor, Zsanett Tárnok, Susanne Walitza, Elif Weidinger - European Child & Adolescent Psychiatry 2021 cited by 64

  20. Genomics and transcriptomics yields a system-level view of the biology of the pathogen Naegleria fowleri

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - BMC Biology 2021 cited by 36

  21. Suppression of Convection Artifacts in Stimulated-Echo Diffusion Experiments. Double-Stimulated-Echo Experiments

    Authors: , - Journal of Magnetic Resonance 1997 cited by 696

  22. Sustainable hydropower in the 21st century

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 688

  23. Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond

    Authors: , , - Pharmacology & Therapeutics 2011 cited by 256

  24. Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

    Authors: , , , , , , , , , - Schizophrenia Research 2010 cited by 255